Next-Generation Sequencing Market by NGS Platforms (Illumina – HiSeq Series, HiSeq X Ten & HiSeq X Five, MiSeq Series, NextSeq 500, Thermo Fisher – SOLiD Series, Ion PGM, Ion Proton, Ion S5 & Ion S5 XL, Pacific Biosciences – PacBio RS II, Sequel System), NGS Data Analysis (ChIP Sequencing, De Novo Sequencing, Exome Sequencing, Methyl Sequencing, RNA Sequencing, Targeted Resequencing, Whole Genome Sequencing), Technology (Ion Semiconductor Sequencing, Pyrosequencing, Sequencing by Ligation, Sequencing by Synthesis, Single-Molecule Real-time Sequencing), Applications (Agriculture and Animal Research, Biomarker Discovery, Diagnostics, Drug Discovery, Personalized Medicine), and End Users (Academic and Research Institutes, Hospitals & Clinics, Pharmaceutical and Biotechnology Companies) and Forecast 2017-2021

Next-Generation Sequencing Market by NGS Platforms (Illumina – HiSeq Series, HiSeq X Ten & HiSeq X Five, MiSeq Series, NextSeq 500, Thermo Fisher – SOLiD Series, Ion PGM, Ion Proton, Ion S5 & Ion S5 XL, Pacific Biosciences – PacBio RS II, Sequel System), NGS Data Analysis (ChIP Sequencing, De Novo Sequencing, Exome Sequencing, Methyl Sequencing, RNA Sequencing, Targeted Resequencing, Whole Genome Sequencing), Technology (Ion Semiconductor Sequencing, Pyrosequencing, Sequencing by Ligation, Sequencing by Synthesis, Single-Molecule Real-time Sequencing), Applications (Agriculture and Animal Research, Biomarker Discovery, Diagnostics, Drug Discovery, Personalized Medicine), and End Users (Academic and Research Institutes, Hospitals & Clinics, Pharmaceutical and Biotechnology Companies) and Forecast 2017-2021

The high demand for scalability, speed and low-cost sequencing has driven the development of next-generation sequencing (NGS) or high-throughput sequencing. It has the potential to dramatically accelerate biological and biomedical research, by enabling the comprehensive analysis of genomes, transcriptomes and interactomes to become inexpensive, routine and widespread, rather than requiring significant production-scale efforts.

The global next-generation sequencing market report estimates the market size (Revenue US$ million – 2014 to 2021) and key market segments based on NGS Platforms (Illumina – HiSeq Series, HiSeq X Ten & HiSeq X Five, MiSeq Series, NextSeq 500, Thermo Fisher – SOLiD Series, Ion PGM, Ion Proton, Ion S5 & Ion S5 XL, Pacific Biosciences – PacBio RS II, Sequel System), NGS Data Analysis (ChIP Sequencing, De Novo Sequencing, Exome Sequencing, Methyl Sequencing, RNA Sequencing, Targeted Resequencing, Whole Genome Sequencing), Technology (Ion Semiconductor Sequencing, Pyrosequencing, Sequencing by Ligation, Sequencing by Synthesis, Single-Molecule Real-time Sequencing), Applications (Agriculture and Animal Research, Biomarker Discovery, Diagnostics, Drug Discovery, Personalized Medicine), and End Users (Academic and Research Institutes, Hospitals & Clinics, Pharmaceutical and Biotechnology Companies), and forecasts growth trends (CAGR% – 2017 to 2021).

The global next-generation sequencing market report also provides the detailed market landscape (market drivers, restraints, opportunities), market attractiveness analysis and profiles of major competitors in the global market including company overview, financial snapshot, key products, technologies and services offered, and recent developments. The global next-generation sequencing market research report is divided by geography (regional and country based) into North America (U.S., Canada), Latin America (Brazil, Mexico, Rest of LA), Europe (U.K., Germany, France, Italy, Spain, Rest of EU), Asia Pacific (Japan, China, India, Rest of APAC), and Rest of the World.

Category:
  1. Introduction
  2. Executive Summary
    • Market Size Estimation (Revenue US$ Million, 2014-2021)
    • Forecast Estimation (Revenue US$ Million and CAGR%, 2017-2021)
  3. Research Methodology
  4. Market Landscape
    • Market Dynamics
      • Drivers
      • Barriers
      • Opportunities
    • Market Share Analysis
      • Companies
      • Products
    • Market Trends Analysis
      • Key success factors
      • Market Growth Rate
    • Market Attractiveness Analysis
    • Market Profitability Analysis
      • Buyer power
      • Supplier power
      • Barriers to entry
      • Threat of substitute products
      • Rivalry among firms in the industry
    • Distribution Channels
  5. Market Segmentation [refer Market Segments and Companies Tab]
    • Product Type (cells, media, serum, vaccine, protein, instrument, etc.)
    • Source Type
    • Reagents and Consumables Type
    • Diagnostic Test
    • Indication Type
    • Technology
    • Diagnostics, Therapeutic or Surgical Application
    • End User Groups
  6. Geography (Region, Country)
    • North America (U.S., Canada)
    • Europe (U.K., Germany, France, Italy, Spain, Rest of EU)
    • Latin America (Brazil, Mexico, Rest of LA)
    • Asia Pacific (Japan, China, India, Rest of APAC)
    • Rest of the World (Middle East & Africa)
  7. Company Profiles [refer Market Segments and Companies Tab]
    • Company Overview
    • Financial Snapshot (FY 2014-2016)
    • Product Portfolio
    • Business Strategies
    • Recent Developments
  8. Recommendations
  9. References

Next-Generation Sequencing Market

1. NGS Platform
1.1. Illumina
1.1.1. HiSeq Series
1.1.2. HiSeq X Ten & HiSeq X Five
1.1.3. MiSeq Series
1.1.4. NextSeq 500
1.2. Life Technologies (Thermo Fisher)
1.2.1. SOLiD Series
1.2.2. Ion PGM (Personal Genome Machine)
1.2.3. Ion Proton
1.2.4. Ion S5 & Ion S5 XL
1.3. Pacific Biosciences
1.3.1. PacBio RS II
1.3.2. Sequel System
1.4. Other Platforms

2. NGS Data Analysis
2.1. ChIP Sequencing
2.2. De Novo Sequencing
2.3. Exome Sequencing
2.4. Methyl Sequencing
2.5. RNA Sequencing
2.6. Targeted Resequencing
2.7. Whole Genome Sequencing (WGS)
2.8. Others

3. Technology
3.1. Ion Semiconductor Sequencing
3.2. Pyrosequencing
3.3. Sequencing by Ligation (SBL)
3.4. Sequencing by Synthesis (SBS)
3.5. Single-Molecule Real-time (SMRT) Sequencing
3.6. Other Technologies

4. Application
4.1. Agriculture and Animal Research
4.2. Biomarker Discovery
4.3. Diagnostics
4.4. Drug Discovery
4.5. Personalized Medicine

5. End User
5.1. Academic and Research Institutes
5.2. Hospitals & Clinics
5.3. Pharmaceutical and Biotechnology Companies

6. Company Profiles
7. Agilent Technologies, Inc.
8. Beijing Genomics Institute
9. Eurofins Scientific
10. GATC Biotech AG
11. Illumina, Inc.
12. Life Sciences Corporation (Roche Holding AG)
13. Macrogen Inc.
14. Oxford Nanopore Technologies, Ltd.
15. Pacific Biosciences of California, Inc.
16. Perkinelmer, Inc.
17. Qiagen N.V.
18. Thermo Fisher Scientific, Inc.

Request market specific full ToC and sample pages for this report

Full Name*

Email*

Phone Number* [Please add country code]

Subject*

Message*